ConductScience.org, home
TYRO3: TYRO3 protein tyrosine kinase
API referenceFor AI assistants

Gene · 7301

NIH grants1,792

NIH grants whose papers are about the gene, through NIH's grant-paper links.

61 to 80 of 1,792

Download this page as JSON
GrantTitleTYRO3 papersNewest fiscal year
P30CA142543UT Southwestern Medical Center Simmons Comprehensive Cancer Center22025
P30CA168524The University of Kansas Cancer Center22025
P30DK034989Yale Liver Center22025
P30DK056338Texas Medical Center Digestive Diseases Center22025
P30DK058404Molecular and Cellular Basis for Digestive Diseases22025
P30EY001792P30 Core Grant for Vision Research22025
P30EY014801Miami Center for Vision Research22025
P50CA116201Mayo Clinic Breast Cancer SPORE22025
P50CA121974Yale SPORE in Skin Cancer22025
P50CA236733Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer22025
P51OD010425Washington National Primate Research Center22025
R01AR043369MITF from control of pigmentation to melanoma risk22025
R01CA129933Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells22025
R01CA163217Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma22025
R01CA253329Role of microbially-derived metabolites in anti-tumor immunity in breast cancer22025
R01CA265095Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia22025
R01DK099097Functional outcomes of inflammatory bowel disease associated variants22025
R15HL152257Dissecting inflammatory outcomes following eCigarette exposure22025
R35HL145228A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques22025
T32AI007496Interdisciplinary Training Program in Immunology22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7301/grants?page=4

API referenceFor AI assistants